Statherin vs Linaclotide
Head-to-head comparison of Statherin (Human statherin) and Linaclotide (Linaclotide) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Statherin | Linaclotide |
|---|---|---|
| Category | Dental & Oral | Gastrointestinal |
| Full Name | Human statherin | Linaclotide |
| Molecular Weight | 5380 Da | 1526.8 Da |
| Half-Life | minutes to hours in saliva | Active locally; negligible systemic half-life |
| Amino Acids | 43 | 14 |
| Typical Dose | 1-50 µM in experimental systems | 72-290 mcg once daily |
| Route | Topical/Intraoral | Oral |
| Purity | ≥98% | ≥98% |
| Studies Count | 95 | 1200 |
| Research Status | Pre-clinical | Clinical |
Statherin Benefits
- ✓enamel pellicle stabilization
- ✓calcium phosphate homeostasis
- ✓remineralization support
- ✓anti-adhesion
Linaclotide Benefits
- ✓improves-bowel-movements
- ✓reduces-abdominal-pain
- ✓increases-intestinal-secretion
- ✓supports-transit
Statherin Dosing
topical peptide exposure in vitro or ex vivo|salivary-mimetic coating studies|surface-conditioning protocols
Linaclotide Dosing
72 mcg PO daily|145 mcg PO daily|290 mcg PO daily
Statherin Side Effects
- ⚠minimal systemic effects expected
- ⚠surface adsorption variability
- ⚠rapid enzymatic breakdown
Linaclotide Side Effects
- ⚠diarrhea
- ⚠abdominal-pain
- ⚠bloating
Research Overview
Statherin
Statherin has been extensively studied as a key regulator of enamel mineral equilibrium and pellicle biology. It is used in biomimetic dentistry research to model or improve enamel protection and remineralization.
Linaclotide
Linaclotide has extensive clinical evidence for chronic idiopathic constipation and IBS-C, with consistent effects on stool frequency and abdominal symptom relief. Its mechanism is local GC-C activation in the gut with minimal systemic exposure.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.